The mechanisms of corticotropin-releasing hormone (CRH)-induced excitation of ACTH-secreting adenoma cells were investigated using the perforated whole-cell 
Introduction
Corticotropin-releasing hormone (CRH) 1 is one of the major regulatory hormones of the neuroendocrine response to stress (1, 2) . Secreted from the hypothalamic CRH-neurons into a pituitary portal system in response to stress, CRH stimulates ACTH secretion from corticotrophs in the anterior pituitary (2) . The mechanism of CRH-induced ACTH secretion has been investigated using rat corticotrophs and AtT-20 cells, an ACTH-secreting mouse pituitary cell line, and ACTH-secreting human pituitary adenoma cells. CRH stimulates ACTH secretion through the activation of adenylyl cyclase (3, 4) and through the increase in intracellular Ca 2 ϩ concentration ([Ca
] i ) (5, 6) . CRH-induced [Ca 2 ϩ ] i increase is due to the Ca 2 ϩ influx through voltage-gated Ca 2 ϩ channels, which is stimulated by CRH through protein kinase A (PKA)-mediated pathways (5, 7) . In addition to CRH-induced activation of voltage-gated Ca 2 ϩ channels, CRH depolarizes ACTH-secreting cells and increases action potential frequency that is accompanied by [Ca 2 ϩ ] i transients (7) . These suggest that the increased frequency of action potential augments Ca 2 ϩ influx through the voltage-gated Ca 2 ϩ channels that are open during action potentials. To understand the significance of the CRH-induced excitation in ACTH secretion, it is necessary to investigate the mechanism of CRH-induced excitation and its relation to [Ca 2 ϩ ] i increase and ACTH secretion. We investigated these ionic mechanisms by electrophysiological experiments using perforated whole-cell clamp on human ACTH-secreting adenoma cells and nonadenoma human corticotrophs. We found that CRH excited ACTH-secreting adenoma cells by activating a nonselective cation current through the PKA-mediated pathway. This CRH-induced activation of a cation current played an important role in CRH-induced [Ca 2 ϩ ] i increase and ACTH secretion. This is the first report that showed CRHinduced activation of a nonselective cation current in vertebrate cells, including human corticotroph.
Methods
Drugs. CRH, PKC (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) , a protein kinase C (PKC) inhibitor peptide, and PKI(5-24), a PKA inhibitor peptide, were purchased from Peninsula Laboratories Inc. (Belmont, CA). 8-bromoadenosine 3 Ј ,5 Ј -cyclic monophosphate (8Br-cAMP), forskolin, and nystatin were purchased from Sigma Chemical Co. (St. Louis, MO). N -[2-( p -bromocinnamylamino)ethyl]-5-isoquinoleinsulfonamide (H89) was purchased from Seikagaku-kogyo Co., Ltd. (Tokyo, Japan), and dispase from Godo Shusei Co., Ltd. (Tokyo, Japan). Fura 2/AM was purchased from Molecular Probes, Inc. (Eugene, OR).
Cell preparation. ACTH-secreting pituitary adenomas were obtained with informed consent from three patients operated for ACTH-secreting pituitary adenoma by transsphenoidal surgery (patients [1] [2] [3] . The use of surgically removed human pituitary tissues obtained during surgery as experimental materials is permitted by the Investigation Committee of Hypothalamo-Pituitary Diseases, The Ministry of Health and Welfare of Japan, and The Ethical Committee of University of Tokyo School of Medicine (Tokyo, Japan). Preoperative serum ACTH levels of these patients were 61 pg/ml in patient 1, 53 pg/ml in patient 2, and 90 pg/ml in patient 3. All three patients re-sponded to 100 g intravenous CRH administration, peak ACTH value was 132 pg/ml in patient 1, 155 pg/ml in patient 2, and 210 pg/ml in patient 3. The excised adenoma tissues were minced into small pieces ( Ͻ 1 mm) and were digested with 1,000 U/ml dispase. For investigating the hormonal release, cells were seeded on 24- ] i measurements, cells were seeded on 22-mm round cover glasses and placed in 35-mm culture dishes. For electrophysiological experiments they were seeded on 35-mm culture dishes. Cells were cultured in DMEM containing 10% heat-inactivated FCS, and kept in humidified air containing 5% CO 2 at 37 Њ C. All the experiments were carried out using cells cultured for 1 to 2 wk.
Nonadenoma human anterior pituitary cells were obtained by transsphenoidal surgery from another patient suffering from Cushing's disease. As part of the surgical procedure, it is sometimes inevitable to remove some small pieces of normal tissue from the anterior pituitary to reveal the adenoma tissue. The patient had been informed about this possibility in advance and he gave his consent that such normal tissue could be used for this experiment in the case that it had to be removed when looking for the adenoma. The normal pituitary tissue was digested and seeded on 35-mm tissue culture dishes by the same method as stated above. Cells were cultured in the same manner as described for the ACTH-secreting adenoma cells. After electrophysiological experiments, cells that responded to CRH application were stained for human ACTH and were confirmed to be ACTH-secreting cells (see Cell identification , below).
Electrophysiology. The perforated whole-cell clamp technique was used (8 ). Other changes in the composition of the extracellular and internal solutions are noted. During the experiments, the extracellular solution was continuously perfused by a peristaltic pump. Agonists were applied by changing the perfusing solution. It took ‫ف‬ 2 min to change the bath solution with this peristaltic pump system. The liquid junction potentials between the standard extracellular solution and other solutions used (internal and external) were measured using a 3 M KCl electrode as a reference, and all the data were corrected for the liquid junction potential ( Ϫ 8 to 2 mV). An amplifier (EPC-7; List Biological Labs, Inc., Campbell, CA) was used for recording the membrane current and potential. All experiments were performed at room temperature (22-25 Њ C). Glass capillaries of 1.5 mm diameter with a filament were used to make patch electrodes. The resistance of the patch electrodes were between 5 and 8 M ⍀ . Details of the perforated whole-cell clamp technique have been reported elsewhere (9) . Current clamp recordings were started after the series resistance fell below 50 M ⍀ . Voltage clamp recordings were made after the series resistance fell below 20 M ⍀ . Since the amplitude of the current was Ͻ 150 pA, the errors caused by series resistance were ignored.
Microinjection of peptides. PKI(5-24) and PKC (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) were injected into the cell by microinjection. The details of the method for microinjection have already been reported (10) . The peptides were dissolved in 150 mM KCl at the concentration of 0.1 mM. The peptide solution was microinjected through microcapillaries with a tip resistance of 20 M ⍀ by pressure injection (110 hPa, 0.1 s). At the time of injection, a slight swelling of the cell was observed. The volume of the injected solution was estimated approximately by the decrease of the solution after multiple injections. The injected solution was ‫ف‬ 10-30 fl per cell, which was ‫ف‬ 1/100 of the cell volume (500-1,500 fl). Microinjection was performed 20 min before patch clamping. The cells with input resistance of more than 1 G ⍀ after the microinjection were used for the experiments. Hormonal release study. Adenoma cells cultured in 24-well dishes were washed twice with serum-free DMEM containing 0.1% BSA. They were incubated with the same medium containing 100 nM CRH for 2 h with or without 2 M nitrendipine or 10 M forskolin. Some cells were pretreated with 5 M H89, a PKA inhibitor, for 1 h. After H89 pretreatment, cells were treated with or without 100 nM CRH for 2 h. For the experiments using Na ϩ -free extracellular solution, cells were incubated in Na ϩ -free extracellular solution (see above) containing 100 mg/dl glucose with or without 100 nM CRH for 2 h. After the incubation with various agents, the solution was collected and stored at Ϫ 20 Њ C until the hormonal assay. ACTH was assayed using a radioimmunometric assay kit (Daiichi Radioisotope Laboratories, Tokyo, Japan).
Cell identification. At an early stage of the experiments, the cells were stained against human ACTH immunocytochemically to identify ACTH-secreting adenoma cells. Cells ( n ϭ 7) that showed membrane hyperpolarizations in response to CRH application (see below) were fixed by 2% formaldehyde in phosphate buffer and stained for human ACTH by using a human ACTH immunostaining kit (DAKO SA, Glostrup, Denmark). All these cells stained positive for ACTH. In the subsequent experiments, data were obtained from cells that satisfied the criteria for pituitary adenoma cells obtained from our experience, which is round-shaped cells with a diameter of 10-20 m that have a smooth glittering surface under a scanning light microscope. These characteristics were apparently different from the characteristics of the spindle-shaped fibroblast-like cells that grew in the adenoma cell culture.
Results
Membrane depolarization by CRH. Fig. 1 A shows a potential record from a human ACTH-secreting adenoma cell under current clamp in the standard extracellular solution. The pipette solution was the standard internal solution. The resting membrane potential of this cell was ‫ف‬ Ϫ52 mV and this cell exhibited spontaneous action potentials. Spontaneous action potentials were observed in 84% of the examined cells (n ϭ 50). Application of 1 nM CRH induced depolarization to the level of Ϫ40 mV and increased action potential frequency. When CRH was washed out from the bath solution, the membrane potential reversed to the basal level. CRH (10 nM)-induced depolarization was observed in 10 out of 10 cells from adenoma 1, 11 out of 12 cells from adenoma 2, and 8 out of 8 cells from adenoma 3. The mean value of depolarization induced by 10 nM CRH was 9.6Ϯ4.5 mV (meanϮSD, n ϭ 29).
To examine the ionic mechanism of this CRH-induced depolarization, whole cell currents were recorded under voltage clamp. Fig. 1 B shows the membrane current of another adenoma cell recorded under voltage clamp at a holding potential of Ϫ48 mV. The membrane conductance was monitored by applying a 60-mV hyperpolarizing pulse once every 10 s. Application of 10 nM CRH evoked an inward shift of the holding current accompanied by an increase in membrane conductance. This inward current was reversible when CRH was washed out from the bath solution.
These results indicate that CRH-induced inward current is responsible for the CRH-induced depolarization. Therefore we investigated the extracellular Na ϩ-dependency of the CRH-induced inward current because Na ϩ was the major cation in the extracellular solution. Characteristics of the CRH-induced current. Fig. 2 A, left and center, shows membrane currents under voltage clamp obtained before (control) and during (CRH) the application of 10 nM CRH, respectively. We used the standard extracellular solution and the holding potential was Ϫ48 mV. The control current was subtracted from the current recorded during the CRH application to obtain CRH-induced current (Fig. 2 A,  right) . The I-V relation of CRH-induced current in Fig. 2 A, right is plotted against the membrane potential in Fig. 2 B, (᭺) , where the data from two other cells are included (᭹ and ᭝). The CRH-activated current showed slight inward rectification. Because the I-V curve was nearly linear between Ϫ48 and Ϫ78 mV, the reversal potential of CRH-induced current was estimated by extrapolating the I-V curve in this segment, which fell between Ϫ20 and 0 mV. This reversal potential was between the equilibrium potential of Na ϩ and K ϩ , which suggests that the CRH-induced current is a nonselective cation current. The slope conductance between Ϫ48 and Ϫ78 mV of the CRH (10 nM)-induced current was 97Ϯ42 pS (meanϮSD, n ϭ 6) in adenoma 1, 185Ϯ73 pS in adenoma 2, and 238Ϯ37 pS in adenoma 3. Fig. 2 C shows the concentration dependency of the CRH-induced conductance in adenoma 3. Maximum response was obtained at Ͼ 10 nM. Because the I-V relation showed little voltage dependency, a ramp test potential was used for further experiments. Fig. 3 A shows the I-V relationship of the membrane current obtained by a ramp test potential over Ϫ120 to Ϫ50 mV in 800 ms from the holding potential of Ϫ48 mV. When the I-V relations of the cell before and during CRH application were extrapolated, the extrapolating lines crossed between Ϫ20 and 0 mV. These indicate that the reversal potential measured approximately by ramp test protocol was close to the reversal potential estimated by pulse step protocol. The reversal potential of the CRH-induced current estimated by ramp pulse was Ϫ10.5Ϯ7.9 mV (n ϭ 6).
The ion selectivity of the channel responsible for the CRHinduced inward current was investigated. In these experiments, the extracellular Na ϩ was replaced with other cations (Li To investigate the permeability of the CRH-induced current for Cl Ϫ , the extracellular Cl Ϫ was reduced to 15 mM by substituting NaCl with isoosmotic sodium methanesulfonate. Application of CRH induced a cation current in the low Cl Ϫ solution (data not shown). The reversal potential of the CRHinduced current was Ϫ8.3Ϯ7.8 (n ϭ 5) and was close to that of the CRH-induced current obtained in the standard extracellular solution containing 140 mM Cl Ϫ . These indicate that the channel for the CRH-induced current is not permeable to Cl Ϫ . To estimate the permeability ratio for Na ϩ and K ϩ of the CRH-induced conductance, the reversal potential of the CRH (10 nM)-induced current was measured using a solution containing only Na ϩ as a cation for extracellular solution and a solution containing only K ϩ as a cation for intracellular solution. The reversal potential was Ϫ8.8Ϯ6.8 mV (n ϭ 5). If we hypothesize that Na ϩ and K ϩ flow are independent, the permeability ratio of CRH-induced current to K ϩ and Na ϩ can be calculated by the Goldmann-Hodgkin-Katz equation (12, 13) :
Where E rev is the reversal potential of CRH-induced current, P K and P Na are permeability for K ϩ and Na culated to be ‫ف‬ 1.4. However, because the I-V curve of the CRH-induced current showed slight inward rectification, the reversal potential estimated by extrapolating the I-V relations between Ϫ48 and Ϫ68 mV may be slightly more hyperpolarized to the true reversal potential. Therefore, P K /P Na may be a little smaller than calculated, meaning that the CRH-induced current may be a little more permeable to Na ϩ than calculated. Extracellular Na ϩ -dependency of the CRH-induced [Ca 2ϩ ] i increase. Application of 10 nM CRH increased [Ca 2ϩ ] i of these cells (Fig. 4 A) in the standard extracellular solution.
This increase was a reversible phenomenon. Fig. 4 B shows ] i increase was examined. Fig. 4 C shows ] i of these cells (Fig. 4 D) , indicating that abolishment of TTX-sensitive Na Fig. 5 A shows the membrane current before and after the application of 10 M forskolin under voltage clamp. A ramp test potential from Ϫ120 to Ϫ50 mV in 800 ms was applied to ob- tain the I-V relationship from the holding potential of Ϫ48 mV. Forskolin (10 M) induced an inward current whose reversal potential was between the equilibrium potential of Na ϩ and K ϩ , suggesting that the induced current was a nonselective cation current. After maximal response was achieved by forskolin, CRH (10 nM) was applied together with forskolin, which did not induce additional change in the membrane current (n ϭ 5). These data indicate that forskolin induced a cation current and occluded the effect of CRH on the membrane current. These suggest that CRH activates the cation current through the activation of an adenylyl cyclase. When a cell-permeable cAMP analogue, 8Br-cAMP (100 nM), was applied to the cell, similar cation current was induced and the effect of CRH on membrane current was occluded by this compound, as was the case for forskolin (data not shown).
PKA-mediated activation of CRH-induced cation current.
To investigate whether PKA is involved in the CRH-induced activation of the cation current, a PKA-inhibitor H89 (14) was used. Fig. 5 B shows the membrane currents before and after the application of CRH (10 nM) in a cell pretreated with 5 M H89 for 30 min. CRH did not induce the cation current in H89-treated cells (n ϭ 7). Because H89 was not a specific inhibitor for PKA, a specific PKA-inhibitor PKI(5-24) was injected into the cell by microinjection technique. As a control peptide, a specific PKC-inhibitor PKC(19-36) was used. Fig. 6 A shows the effect of CRH on the membrane current of a cell microinjected with PKI(5-24). CRH did not induce any change on the membrane current. Microinjection of PKC(19-36) did not abolish the CRH-induced activation of the cation current (Fig.  6 B) . Fig. 6 C summarizes ] i in various kinds of cells (15) (16) (17) . Because CRH increased [Ca 2ϩ ] i of these ACTH-secreting adenoma cells, it is possible that the CRH-induced cation current is one of the Ca 2ϩ -activated cation currents. To investigate this, we loaded the cell with cell-permeable Ca 2ϩ chelator, BAPTA/AM, to clamp the [Ca 2ϩ ] i lower than 100 nm, at which Ca 2ϩ -activated cation currents are activated (18) . Finally, it reached ‫ف‬ 30 nM at 100 min. Application of CRH (10 nM) did not increase [Ca 2ϩ ] i at this point. When the results from five experiments were summarized, the value of [Ca 2ϩ ] i after 100 min BAPTA/AM treatment was 25Ϯ10 nM and ranged between 15 and 45 nM. It did not increase after the application of CRH (10 nM) and remained around 27Ϯ17 nM, ranging between 20 and 50 nM. Therefore, treating the cell with BAPTA/AM for 100 min was enough to clamp [Ca 2ϩ ] i lower than 50 nM even when CRH is to be applied. We investigated the effect of CRH (10 nM) on the membrane current after treating the cell with BAPTA/AM as mentioned above. In addition to the treatment by BAPTA/AM, we used Ca 2ϩ -free extracellular solution to avoid the local [Ca 2ϩ ] i increase beneath the plasma membrane due to the Ca 2ϩ influx through the voltage-gated Ca 2ϩ channels. Fig. 7 B shows the membrane current evoked by a ramp test potential before and after the application of CRH (10 nM) on a BAPTA/AM-treated cell. CRH induced a cation current in this cell. Application of CRH induced a cation current in the BAPTA/AM-treated (100 min) cells in Ca 2ϩ -free extracellular solution in six out of six cells, including this cell. These data suggest that the cation current induced by CRH is not a member of the Ca 2ϩ -activated cation currents. Hormone release study. To estimate the role of CRH-induced cation current in CRH-induced hormone secretion, human ACTH secretion from adenoma cells was measured. Adenoma cells were incubated in Na ϩ -free extracellular solution, and the effect of CRH application on the ACTH secretion was examined. Fig. 8 shows the effects of CRH on ACTH secretion from primary cultured cells of adenoma 1. CRH increased ACTH secretion in Na ϩ -containing extracellular solution with a concentration dependency. CRH (100 nM) increased the secretion to the level of 300Ϯ45% (meanϮSD, n ϭ 4) of the control. The CRH-induced increase of ACTH secretion was abolished in Na Activation of a nonselective cation current in nonadenoma corticotroph by CRH. To investigate whether the activation of the nonselective cation current was specific in adenoma cells or a common feature in corticotrophs, nonadenoma anterior pituitary cells were used. These cells were primary cultured from a small fragment of the nonadenoma anterior pituitary tissue that had to be resected to make approach to the adenoma during the transsphenoidal procedure (see Cell preparation, Methods). It was difficult to distinguish between corticotrophs and other cell types morphologically. Therefore, we randomly challenged the cells with CRH (10 nM) under voltage clamp. In 4 out of 28 cells, application of CRH activated a cation current. Fig. 9 shows representative current records evoked by a ramp test potential before and after the application of CRH. The reversal potential was close to 0 mV, suggesting that the current was a nonselective cation current. All the four cells were stained positive for human ACTH and only 1 of the 24 cells that did not respond to CRH were stained positive for human ACTH. These indicate that CRH activates a nonselective cation current in at least some of the nonadenoma corticotrophs.
Discussion
CRH is the major regulatory peptide of the neuroendocrine response to stress (2) . It is secreted from hypothalamic CRH neurons and excites ACTH-secreting cells in the anterior pituitary. The mechanism of this excitation was investigated by using human ACTH-secreting adenoma cells in this study. These Effect of CRH on a nonadenoma cell. Resting potential was Ϫ58 mV. Application of CRH (10 nM) induced a current with reversal potential ‫ف‬ 0 mV. Holding potential and ramp pulse protocols were the same as those in Fig. 3 A. Control, current record before the application of CRH; CRH-treated, current record after the application of CRH; and wash, current record after washing out CRH from the extracellular solution. adenoma cells were excited by the application of CRH and secreted ACTH in vitro. The excitation was caused by CRHinduced depolarization through the activation of a nonselective cation current. The I-V curve of this cation current showed slight inward rectification. ] i was higher than 100 nM. Therefore, these data suggest that CRH-activated nonselective cation current is not a member of the Ca 2ϩ -activated cation currents. The activation of this current was mimicked by forskolin and 8Br-cAMP. Microinjection of PKA inhibitor peptide into the cell abolished the activation of the CRH-induced current. These data indicate that the mechanism of CRH-induced activation of the nonselective cation current was mediated by PKA. Modulation of ionic channels through PKA-mediated phosphorylation is reported for voltage-gated Ca 2ϩ and K ϩ channels in several types of cells (19, 20) . In human growth hormonesecreting adenoma cells, GHRH excited the cells by activating a nonselective cation current through a PKA-mediated mechanism (21) . The activation of the nonselective cation current may be a common mechanism of excitation in human anterior pituitary cells for agonists that stimulate cAMP production.
The excitation of the corticotrophs by CRH has been investigated in rat pituitary (22) . There were obvious differences between rat corticotrophs and these human ACTH-secreting adenoma cells in the mechanism of CRH-induced excitation. (a) The excitation in rat corticotrophs are suggested to be due to the inhibition of K ϩ conductance, and not by an increase in cation conductance. (b) The excitation by CRH was not completely blocked by H89 in rat corticotrophs, whereas it was almost abolished by H89 or PKI(5-24) in human ACTHsecreting adenoma cells. The differences in the mechanism of CRH-induced excitation in the ACTH-secreting cell may be due to the difference of species or the difference between normal cells and adenoma cells. The former may be the case because CRH also induced a cation current in nonadenoma human corticotrophs. The combination of the activation of a nonselective cation current and inhibition of K ϩ conductance is a very commonly observed response to neurotransmitters and hormones and typically the two components differ in magnitude among cells (23) (24) (25) . It may simply be that the balance between these two pathways is different between rat and human corticotrophs.
CRH-induced depolarization was previously reported in human ACTH-secreting adenoma cells by Mollard et al. (26) . In their report, application of CRH depolarized the membrane with an increase in input resistance. They speculated that the depolarization is due to the inhibition of K ϩ conductance. In the adenoma cells in this article, the excitation was due to the activation of a nonselective cation current. The difference in the mechanism of excitation is very interesting because it suggests an unknown variety of mechanisms of tumorigenesis in human ACTH-secreting adenomas. However, the difference may be due to the difference of experimental technique. In the report of Mollard et al. (26) , they employed an intracellular recording technique. In this report, we used the perforated whole-cell clamp. Further studies are needed to understand the relation between the CRH-induced inhibition of membrane conductance in their study and CRH-induced nonselective cation conductance revealed in our study.
In ] i is closely related to ACTH secretion rate in ACTH-secreting cells (27, 28) , the CRH-induced [Ca 2ϩ ] i increase due to membrane depolarization stimulates ACTH secretion. Therefore, CRH-induced depolarization may play a major role in CRHinduced ACTH secretion. This speculation is supported by the following observations: (a) both the CRH-induced cation current (which causes depolarization) and CRH-induced ACTH secretion were abolished in Na ] i increase were not abolished by TTX. These indicate that extracellular Na ϩ -dependent depolarization is crucially important in CRH-induced ACTH secretion. However, the significance of the CRH-induced nonselective cation current in CRH-induced ACTH secretion was not examined in nonadenoma corticotrophs because the amount of the nonadenoma tissue available was limited. This question needs further study to solve.
